Skip to content

Oral Curcumin Supplementation in Middle-Aged and Older Adults Improves Vascular Function

Clinical Translation of Curcumin Therapy to Treat Arterial Aging

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01968564
Enrollment
118
Registered
2013-10-24
Start date
2013-06-30
Completion date
2017-06-30
Last updated
2017-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Aging

Brief summary

The proposed study will assess the ability of curcumin, the active ingredient in the Indian spice tumeric, to improve the function of arteries with age. Overall, the proposed research project has the long-term potential to influence clinical practice guidelines by establishing a novel, easy to deliver, cost-effective therapy for treating age-associated arterial dysfunction and reducing the risk of cardiovascular disease with age.

Interventions

DRUGPlacebo pill

sugar and other inert substances

DRUGHigh-dose curcumin pill

2000mg curcumin pill/day

DRUGLow-dose curcumin pill

500mg curcumin pill/day

Sponsors

University of Colorado, Boulder
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
45 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* women must be postmenopausal * body mass index (BMI) \<40 kg/m2 * weight stable in the prior 3 months * absence of clinical disease as determined by medical history, physical examination, blood and urine chemistries, ankle-brachial index, and a graded exercise stress test with monitoring of blood pressure and 12-lead ECG

Design outcomes

Primary

MeasureTime frameDescription
Arterial Stiffness12 weeksArterial pulse wave velocity
Nitric-oxide mediated endothelium-dependent dilation12 weeksflow-mediated dilation and forearm blood flow responses to acetylcholine in the presence and absence of N'-monomethyl-L-arginine

Secondary

MeasureTime frameDescription
Systemic oxidative stress and inflammation12 weekscirculating markers of oxidative stress and inflammation
Endothelial cell oxidative stress and inflammation12 weeksinflammatory and oxidative stress markers in biopsied vascular and arterial endothelial cells

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026